↓ Skip to main content

Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial

Overview of attention for article published in BMC Infectious Diseases, May 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
2 news outlets

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
121 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Published in
BMC Infectious Diseases, May 2021
DOI 10.1186/s12879-021-06130-7
Pubmed ID
Authors

Keivan Ranjbar, Mohsen Moghadami, Alireza Mirahmadizadeh, Mohammad Javad Fallahi, Vahid Khaloo, Reza Shahriarirad, Amirhossein Erfani, Zohre Khodamoradi, Mohammad Hasan Gholampoor Saadi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 121 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 11%
Student > Master 10 8%
Other 8 7%
Researcher 7 6%
Student > Postgraduate 6 5%
Other 21 17%
Unknown 56 46%
Readers by discipline Count As %
Medicine and Dentistry 32 26%
Pharmacology, Toxicology and Pharmaceutical Science 10 8%
Biochemistry, Genetics and Molecular Biology 6 5%
Philosophy 2 2%
Agricultural and Biological Sciences 2 2%
Other 10 8%
Unknown 59 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 June 2021.
All research outputs
#2,779,669
of 23,308,124 outputs
Outputs from BMC Infectious Diseases
#878
of 7,804 outputs
Outputs of similar age
#70,438
of 440,505 outputs
Outputs of similar age from BMC Infectious Diseases
#31
of 207 outputs
Altmetric has tracked 23,308,124 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,804 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,505 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 207 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.